A Study in Adolescent Females to Explore Cytomegalovirus Infection

Infections, Cytomegalovirus Clinical Trial

Official title:
A Study in Adolescent Females to Explore Cytomegalovirus Infection

Status Completed

Clinical Trial Summary

The purpose of this study is to estimate the incidence of Cytomegalovirus (CMV) secondary infections (re-infections/re-activations) and the incidence of CMV primary infections in adolescent females.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01691820
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	N/A
Start date	October 5, 2012
Completion date	April 8, 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06057194` - Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.	Phase 2
Completed	`NCT01357915` - Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine	N/A
Completed	`NCT00435396` - Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects	Phase 1
Completed	`NCT01251744` - Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus	N/A